Neion Bio uses advances in stem cell biology and genetic engineering to completely reimagine the biopharmaceutical production process.
Neion Bio has raised $23.0M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
Neion Bio's investors include Caffeinated Capital, Basis Set Ventures, Haystack, Digitalis Ventures, Trust Ventures.
Neion Bio is headquartered in Yorkshire, United States.
Neion Bio uses advances in stem cell biology and genetic engineering to completely reimagine the biopharmaceutical production process.
Neion Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neion Bio — Funding & Investors." VCBacked, June 11, 2026, https://www.vcbacked.co/company/neion-bio. Accessed July 19, 2026.
VCBacked. (2026). Neion Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/neion-bio
{{cite web |title=Neion Bio — Funding & Investors |url=https://www.vcbacked.co/company/neion-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated